RDN Q3 Earnings Beat on Specialty Strength, Revenues Rise Y/Y

Radian Group reported Q3 2026 adjusted operating income of $1.44 per share, up 25.2% year over year and 13.4% above consensus, while revenue rose 105.9% to $624.1 million but missed estimates by 4.5%. Specialty Insurance underwriting strengthened, with its combined ratio improving to 80.4% from 97.7% sequentially; mortgage insurance defaults and elevated expenses were headwinds. Radian repurchased $135 million of shares during the quarter and another $117 million in October, and its Inigo acquisition increased Specialty’s contribution to approximately 34% of adjusted pretax operating income before corporate expenses.

Analysis

RDN’s beat is less clean than the EPS headline suggests: growth is acquisition-led, while mortgage pretax income fell and both segments benefited from favorable reserve development. The key test is whether Inigo can sustain underwriting profitability after catastrophe losses and reserve releases normalize—not whether Specialty’s quarterly combined ratio repeats. Its 34% contribution to pretax income before corporate costs is meaningful diversification, but also makes consolidated results more exposed to specialty-market pricing and loss volatility.

For the next 1–3 months, watch the Title divestiture’s closing conditions and capital proceeds, alongside Specialty’s loss picks and mortgage defaults/persistency. Over 6–18 months, mortgage insurance in force and excess PMIERs assets support capital returns, but falling new insurance written could eventually slow premium growth. Higher fixed-maturity income is a tailwind while reinvestment yields remain attractive; rate declines would erode that support over time. Buybacks are supportive, but do not resolve underwriting-quality risk.

Contrarian read: the reported growth rate overstates organic momentum, while the mortgage book’s rising defaults and lower production are easy to underweight amid acquisition optics. Conversely, the mortgage segment’s large in-force book and capital cushion may make near-term default deterioration more manageable than the headline ratio implies. Everest Group’s underwriting loss is not a direct valuation comp, but cautions against assuming benign industry loss experience.

Key Decisions for Investors

• Do not chase the earnings beat. Consider a modest RDN long only on post-earnings weakness, with the thesis contingent on Specialty profitability holding up without material favorable reserve development; cut or reassess if loss experience drives a clear deterioration in its combined ratio.
• Track next-quarter mortgage defaults, persistency, and new insurance written together. A continued rise in defaults alongside weaker persistency and production would falsify the view that the in-force book can offset slower new business.
• Treat the remaining buyback authorization as a capital-return backstop, not an earnings catalyst. Verify holding-company liquidity, PMIERs excess, and the Title sale’s closing and proceeds before underwriting additional capital deployment.
• No compelling pair trade versus EG, PFG, or PRU from this report alone: their business mixes and reported drivers differ. Use their results as broad insurance-sector context, not as direct RDN comparables.